INTUITIVE SURGICAL INC (IUI1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:IUI1 - US46120E6023 - Common Stock
445.85 EUR
-6.8 (-1.5%)
IUI1 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. IUI1 gets an excellent profitability rating and is at the same time showing great financial health properties. IUI1 is quite expensive at the moment. It does show a decent growth rate. This makes IUI1 very considerable for quality investing!
1. Profitability
1.1 Basic Checks
- IUI1 had positive earnings in the past year.
- In the past year IUI1 had a positive cash flow from operations.
- Of the past 5 years IUI1 4 years were profitable.
- Of the past 5 years IUI1 4 years had a positive operating cash flow.
1.2 Ratios
- IUI1's Return On Assets of 14.19% is amongst the best of the industry. IUI1 outperforms 92.06% of its industry peers.
- Looking at the Return On Equity, with a value of 16.12%, IUI1 belongs to the top of the industry, outperforming 84.13% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 11.69%, IUI1 belongs to the best of the industry, outperforming 84.13% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for IUI1 is in line with the industry average of 9.95%.
- The 3 year average ROIC (9.53%) for IUI1 is below the current ROIC(11.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 11.69% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)9.53%
ROIC(5y)9.27%
1.3 Margins
- With an excellent Profit Margin value of 28.58%, IUI1 belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
- In the last couple of years the Profit Margin of IUI1 has declined.
- Looking at the Operating Margin, with a value of 29.44%, IUI1 belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
- IUI1's Operating Margin has declined in the last couple of years.
- IUI1's Gross Margin of 66.38% is fine compared to the rest of the industry. IUI1 outperforms 73.02% of its industry peers.
- In the last couple of years the Gross Margin of IUI1 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IUI1 is creating some value.
- There is no outstanding debt for IUI1. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- There is no outstanding debt for IUI1. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.17
WACC10.02%
2.3 Liquidity
- IUI1 has a Current Ratio of 4.97. This indicates that IUI1 is financially healthy and has no problem in meeting its short term obligations.
- IUI1 has a Current ratio of 4.97. This is amongst the best in the industry. IUI1 outperforms 96.83% of its industry peers.
- IUI1 has a Quick Ratio of 4.20. This indicates that IUI1 is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Quick ratio value of 4.20, IUI1 belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 21.83% over the past year.
- Measured over the past years, IUI1 shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.42% on average per year.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.76%
3.2 Future
- IUI1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.07% yearly.
- Based on estimates for the next years, IUI1 will show a quite strong growth in Revenue. The Revenue will grow by 12.31% on average per year.
EPS Next Y11.25%
EPS Next 2Y13.22%
EPS Next 3Y13.64%
EPS Next 5Y15.07%
Revenue Next Year15.2%
Revenue Next 2Y14.36%
Revenue Next 3Y13.92%
Revenue Next 5Y12.31%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 58.59, IUI1 can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of IUI1 is on the same level as its industry peers.
- The average S&P500 Price/Earnings ratio is at 27.25. IUI1 is valued rather expensively when compared to this.
- With a Price/Forward Earnings ratio of 52.70, IUI1 can be considered very expensive at the moment.
- Based on the Price/Forward Earnings ratio, IUI1 is valued a bit more expensive than 69.84% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.98. IUI1 is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.59 | ||
| Fwd PE | 52.7 |
4.2 Price Multiples
- IUI1's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. IUI1 is more expensive than 66.67% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of IUI1 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 81.71 | ||
| EV/EBITDA | 51.36 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IUI1 does not grow enough to justify the current Price/Earnings ratio.
- IUI1 has a very decent profitability rating, which may justify a higher PE ratio.
- IUI1's earnings are expected to grow with 13.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.21
PEG (5Y)2.73
EPS Next 2Y13.22%
EPS Next 3Y13.64%
5. Dividend
5.1 Amount
- IUI1 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
INTUITIVE SURGICAL INC / IUI1.DE FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 5 / 10 to IUI1.DE.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (IUI1.DE). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (IUI1.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for IUI1 stock?
The financial health rating of INTUITIVE SURGICAL INC (IUI1.DE) is 7 / 10.